IP Library Granted Patent US 10,111,822
Granted Patent B2
US 10,111,822 · App. 14/655,068 · Granted Oct 30, 2018

External dermal composition for anti-ageing and method for producing the same

Inventors: Takashi Shibuya (Okayama, JP); Akiko Miyake (Okayama, JP); Tatsuya Ishihara (Okayama, JP); Masaki Miyake (Okayama, JP); Hitomi Wake (Okayama, JP)
Assignee: HAYASHIBARA CO., LTD.
A61K8/676A61K8/345A61K8/498A61K8/4926A61K8/4953A61K8/602A61K8/64A61K8/922A61K8/97A61K8/9771A61K8/9789A61K8/988A61K31/7048A61Q19/00A61Q19/02A61Q19/08A61K2800/5922A61K2800/805
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,111,822
App. No.
14/655,068
Granted
Oct 30, 2018
Kind
B2
Abstract

The present invention has an object to provide an external dermal composition for anti-ageing, which prevents or improves apparent skin problems such as wrinkles, fine wrinkles, blemishes, and saggings caused by increasing age or ageing; and maintains or improves the barrier function and the hyaluronic acid production in the skin. The object is solved by providing an external dermal composition for anti-ageing, which contains an aqueous medium as a base material and one or more ingredients selected from L-ascorbic acid, derivatives thereof, and their salts as an effective ingredient(s).

Claims (14)

1. A composition which comprises 2-O-α-D-glucosyl-L-ascorbic acid and sodium salt thereof that are in a crystalline form.

2. The composition of claim 1 , wherein the ratio of said 2-O-α-D-glucosyl-L-ascorbic acid and said sodium salt thereof is in the range of 60:40 to 45:55 by mass, on a dry solid basis.

3. The composition of claim 1 , wherein said sodium salt of 2-O-α-D-glucosyl-L-ascorbic acid in a crystalline form is a hydrous crystalline sodium salt of 2-O-α-D-glucosyl-L-ascorbic acid having diffraction angles (2θ) of 6.8°, 8.2°, 14.3°, 17.8°, and 18.4°; or an anhydrous crystalline sodium salt of 2-O-α-D-glucosyl-L-ascorbic acid having diffraction angles (2θ) of 8.0°, 9.0°, 16.4°, 17.9°, and 20.8°, when determined on powder X-ray diffraction analysis.

4. A crystal of sodium salt of 2-O-α-D-glucosyl-L-ascorbic acid.

5. The crystal of claim 4 , which is in a hydrous crystalline form having diffraction peaks at diffraction angles (2θ) of 6.8°, 8.2°, 14.3°, 17.8°, and 18.4°, or in an anhydrous crystalline form having diffraction peaks at diffraction angles (2θ) of 8.0°, 9.0°, 16.4°, 17.9°, and 20.8°.

6. The crystal of claim 5 , wherein said hydrous crystal belongs to an orthorhombic system and exhibits a space group of Pbca (#61) and a lattice constant of a=6.9733 Å, b=14.4839 Å, c=19.3221 Å, and V=1951.54 Å 3 .

7. A method for producing said crystal of sodium salt of 2-O-α-D-glucosyl-L-ascorbic acid of claim 4 , which comprises the steps of:

(a) dissolving 2-O-α-D-glucosyl-L-ascorbic acid in an aqueous sodium hydroxide solution;

(b) adding an organic solvent to the resulting solution;

(c) allowing the resulting mixture to stand to precipitate a crystal of sodium salt of 2-O-α-D-glucosyl-L-ascorbic acid; and

(d) collecting the precipitated crystal.

8. A composition comprising the crystal of sodium salt of 2-O-α-D-glucosyl-L-ascorbic acid of claim 4 .

9. The composition of claim 8 , which further comprises L-ascorbic acid or its derivative including a glycosyl-, acyl-, or phosphoryl-derivative of L-ascorbic acid.

10. The composition of claim 9 , wherein said glycosyl-derivative of L-ascorbic acid is 2-O-α-D-glucosyl-L-ascorbic acid.

Assignments (2)
CHANGE OF NAME Recorded Mar 18, 2025
From: HAYASHIBARA CO., LTD.
To: NAGASE VIITA CO., LTD.
Reel/Frame 070538/0828 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 24, 2015
From: SHIBUYA, TAKASHI; MIYAKE, AKIKO; ISHIHARA, TATSUYA; MIYAKE, MASAKI; WAKE, HITOMI
To: HAYASHIBARA CO., LTD.
Reel/Frame 035964/0835 →
Priority Claims (3)
JP 2012-285949 · Dec 27, 2012 · national
JP 2012-285958 · Dec 27, 2012 · national
WO PCT/JP2013/077768 · Oct 11, 2013 · international
Continuity (1)
Related Publication 20150342854A1 · Dec 3, 2015
Cited By (1)
US 12,458,620